NEW YORK (GenomeWeb News) – Life Technologies and Nanosys have entered into a cross-licensing deal to share rights to intellectual property covering fluorescent nanocrystals, which are also called quantum dots.

The firms said that the deal is expected to result in the development of new tools to detect counterfeit products worldwide. The firms said that between them they have over 270 patents and applications, including 84 issued US patents, for using fluorescent nanocrystals.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.